185 related articles for article (PubMed ID: 18724016)
41. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
42. Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention.
Gao MD; Zhang EY; Liu YY; Li XW; Xiao JY; Sun GY; Liu Y
Chin Med J (Engl); 2020 Apr; 133(7):766-772. PubMed ID: 32149760
[TBL] [Abstract][Full Text] [Related]
43. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis.
Iwakura K; Ito H; Okamura A; Koyama Y; Date M; Higuchi Y; Inoue K; Kimura R; Nagai H; Imai M; Toyoshima Y; Ozawa M; Ito N; Okazaki Y; Shibuya M; Suenaga H; Kubota A; Fujii K
Circ J; 2009 May; 73(5):925-31. PubMed ID: 19325192
[TBL] [Abstract][Full Text] [Related]
44. Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention.
Youssef AA; Wu CJ; Hang CL; Cheng CI; Yang CH; Chen CJ; Chen YH; Chai HT; Chua S; Yeh KH; Yip HK
Circ J; 2006 Dec; 70(12):1538-42. PubMed ID: 17127795
[TBL] [Abstract][Full Text] [Related]
45. Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial.
Huang D; Wu H; Zhou J; Zhong X; Gao W; Ma Y; Qian J; Ge J
Am Heart J; 2022 Feb; 244():86-93. PubMed ID: 34785173
[TBL] [Abstract][Full Text] [Related]
46. [Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction].
Gan LJ; Zhang CH; Zhang M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):348-51. PubMed ID: 20669666
[TBL] [Abstract][Full Text] [Related]
47. Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP).
Minamino T; Jiyoong K; Asakura M; Shintani Y; Asanuma H; Kitakaze M;
Circ J; 2004 Feb; 68(2):101-6. PubMed ID: 14745142
[TBL] [Abstract][Full Text] [Related]
48. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
49. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
50. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.
Ikeda N; Yasu T; Kubo N; Hashimoto S; Tsuruya Y; Fujii M; Kawakami M; Saito M
Heart; 2004 Feb; 90(2):181-5. PubMed ID: 14729792
[TBL] [Abstract][Full Text] [Related]
51. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
52. [Protective effect of ischemia postconditioning on reperfusion injury in patients with ST-segment elevation acute myocardial infarction].
Liu TK; Mishra AK; Ding FX
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):35-9. PubMed ID: 21418794
[TBL] [Abstract][Full Text] [Related]
53. Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention.
Pi SF; Liu YW; Li T; Wang Y; Zhou Q; Liu BJ; Peng WJ; Li X; Wang YY; Huang L
J Thorac Dis; 2019 Mar; 11(3):744-752. PubMed ID: 31019762
[TBL] [Abstract][Full Text] [Related]
54. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
[TBL] [Abstract][Full Text] [Related]
55. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
[TBL] [Abstract][Full Text] [Related]
56. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
57. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
58. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI.
Kostic J; Djordjevic-Dikic A; Dobric M; Milasinovic D; Nedeljkovic M; Stojkovic S; Stepanovic J; Tesic M; Trifunovic Z; Zamaklar-Tifunovic D; Radosavljevic-Radovanovic M; Ostojic M; Beleslin B
Cardiovasc Ultrasound; 2015 May; 13():26. PubMed ID: 26012474
[TBL] [Abstract][Full Text] [Related]
59. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction.
Claeys MJ; Bosmans J; De Ceuninck M; Beunis A; Vergauwen W; Vorlat A; Vrints CJ
Am J Cardiol; 2004 Jul; 94(1):9-13. PubMed ID: 15219500
[TBL] [Abstract][Full Text] [Related]
60. Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction: based on the Korea Acute Myocardial Infarction Registry (KAMIR).
Yang MJ; Lee HC; Lee HW; Park JS; Oh JH; Choi JH; Cha KS; Kim SP; Kim W; Jeong MH
Int J Cardiol; 2013 Oct; 168(5):4868-9. PubMed ID: 23899744
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
